- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 13, 2025 | 30.3M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $2.46M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $1.68M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $5.58M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $6.12M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $5.93M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $6.97M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $18.15M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $17.88M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $25.66M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $26.21M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 30.1M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 30.03M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $62K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$514K |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $18.57M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $18.89M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $18.86M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.01 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.02 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.01 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.02 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $972K |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $1.86M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$382K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$441K |
| Net Income | Q2 2025 · Sep 30, 2023 | −$59K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$452K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$506K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $520K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $1.35M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $10.99M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $23.07M |